2 results
Approved WMOCompleted
The primary objective(s) of this study is:- To determine the relative bioavailability of etoricoxib 120 mg tablets manufactured at Frosst Iberica, Spain and Elkton, VA, USA.
Approved WMOCompleted
With this study we aim to determine the feasibility of SuperSeton placement in patients with perianal fistulas.